How many insider trades does FilingIQ track for ETON?

FilingIQ tracks 111 Form 4 insider transactions for ETON (Eton Pharmaceuticals, Inc.), covering filings from Nov 15, 2018 onwards. 4 of those were filed in the last 90 days.

Are ETON insiders net buyers or net sellers?

Across the full Form 4 history for ETON, 29 transactions (26%) were open-market purchases and 46 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ETON insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ETON in?

Eton Pharmaceuticals, Inc. (ETON) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $458.04M.

ETON insider trading

Healthcare

Eton Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

111

Last 90 days

Buys / sells

26% / 41%

Market cap

$458.04M

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Company website: www.etonpharma.com

ETON insider activity at a glance

FilingIQ has scored 111 insider transactions for ETON since Nov 15, 2018. The most recent filing in our index is dated Apr 21, 2026.

Across the full history, 29 open-market purchases and 46 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ETON insider trades is 51.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ETON trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding ETON

Opaleye Management Inc.

$48.36M · 6.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for ETON?: FilingIQ tracks 111 Form 4 insider transactions for ETON (Eton Pharmaceuticals, Inc.), covering filings from Nov 15, 2018 onwards. 4 of those were filed in the last 90 days.
Are ETON insiders net buyers or net sellers?: Across the full Form 4 history for ETON, 29 transactions (26%) were open-market purchases and 46 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ETON insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ETON in?: Eton Pharmaceuticals, Inc. (ETON) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $458.04M.

Methodology & sources

Every ETON insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.